Searching for Reta in Vancouver? Reta is the common short-form for Retatrutide, the triple GLP-1/GIP/glucagon receptor agonist, the most comprehensive metabolic research peptide currently available. Vancouver Island Peptides offers Retatrutide synthesized at our Vancouver, BC lab partner, giving West Coast researchers a local supply chain and available analytical reports for selected strengths.
Most peptide suppliers serving Canadian researchers import their Retatrutide from overseas, primarily from Chinese synthesis facilities. While this keeps headline prices low, it introduces significant drawbacks for researchers in Vancouver and across BC:
By choosing Retatrutide synthesized in Vancouver, BC, you eliminate every one of these risks. The compound never leaves the province. It's produced, tested, and shipped from within British Columbia.
Retatrutide (research compound code LY3437943) is a triple receptor agonist. Where Semaglutide targets one pathway and Tirzepatide targets two, Retatrutide activates three complementary metabolic pathways:
That third pathway is what sets Reta apart: glucagon receptor activation raises energy expenditure rather than only reducing intake, which is why Retatrutide is the most closely watched metabolic research compound in the GLP-1 class.
| Retatrutide 10mg | $285.00 | Full kit, In Stock |
| Retatrutide 20mg | $445.00 | Full kit, In Stock |
| Retatrutide 30mg | $570.00 | Full kit, In Stock |
Both formats are lyophilized powder in sterile vials, synthesized at our Vancouver, BC lab partner. See the product listing for current specifications and available analytical reports.
Buy Retatrutide Canada →If you're a researcher in Vancouver, the choice is simple. Ordering Reta from a Canadian supplier that imports from overseas still means your shipment goes through customs, often at the same Vancouver port or YVR cargo facility where imported goods are inspected. A shipment from Vancouver Island Peptides, by contrast, moves entirely within BC:
Reta is the common short-form for Retatrutide (research code LY3437943), a triple GLP-1/GIP/glucagon receptor agonist. If you searched for Reta in Vancouver, you are looking for Retatrutide, the same compound.
Retatrutide is not approved by Health Canada as a pharmaceutical drug. It is available as a research compound for laboratory research purposes only. Vancouver Island Peptides supplies Retatrutide strictly for research use. Research products. Not for human consumption.
Yes. Retatrutide 10mg, 20mg, and 30mg vials are in stock and shipping from Vancouver Island Peptides. Orders placed before noon typically ship the same or next business day. We ship Canada-wide from within BC.
Tirzepatide is a dual GLP-1/GIP agonist. Retatrutide adds glucagon receptor activation, which increases energy expenditure on top of appetite regulation, making it the most comprehensive metabolic research compound of the three major agonists. Both are available domestically from Vancouver Island Peptides.
Published analytical reports for selected strengths are available on our Lab Reports page.
Buy Retatrutide Canada →We are a Canadian-owned peptide supplier based on Vancouver Island, BC. Every compound is synthesized at a Vancouver, BC lab partner, never imported, never dropshipped. We accept Interac e-Transfer for every order, and BTC or USDC (on Ethereum). Canada-wide shipping in discreet packaging.
Disclaimer: Vancouver Island Peptides supplies research compounds for laboratory research purposes only. Research products. Not for human consumption. Our products are not approved by Health Canada for human or veterinary use. No claims are made regarding the efficacy or safety of these compounds for any specific application. By purchasing, you acknowledge that you are purchasing for research purposes only. Consult a qualified healthcare provider before any personal use.
© 2026 Vancouver Island Peptides. All rights reserved.